C08B 37/12
Agar-agar
Official title: Agar-agar; Derivatives thereof (not used)
C08B37/12 (Agar-agar) appears on 4 US grants and 5 published applications in this corpus.
Search patents in C08B- Granted patents
- 4
- Published applications
- 5
- Assignees
- 5
- Inventors
- 24
- Latest grant
- 6 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 2 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
By publication year.
Subgroups
Granted patents
Recent patents
- Polymer material and method for producing same6 May 2025US 12,291,607 B2Osaka University
- Culture medium additive, culture medium composition, and method for culturing cells or tissue using same9 Feb 2021US 10,914,725 B2Nissan Chemical Industries, Ltd.
- Process for preparing an algal powder containing a reduced content of proteins, and bioplastic composition formulated from such a powder22 Dec 2020US 10,870,733 B2Eranova
- Capture of pathogenic and non-pathogenic biopolymers and bioparticles16 Feb 2016US 9,260,536 B2
- Preparation method for low-temperature sol-agar26 Jun 2025US 2025/0206852 A1Jimei University
- Polymer material and method for producing same19 May 2022US 2022/0153934 A1Osaka University
- Process for preparing an algal powder containing a reduced content of proteins, and bioplastic composition formulated from such a powder13 Sep 2018US 2018/0258231 A1Eranova
- Culture medium additive, culture medium composition, and method for culturing cells or tissue using same17 May 2018US 2018/0136196 A1Nissan Chemical Industries, Ltd.
- Capture of pathogenic and non-pathogenic biopolymers and bioparticles26 Jun 2014US 2014/0178439 A1
Most cited
By later US patents